Drugs / flu matrix peptide p58-66
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00003792 | Apr 1999 → Oct 2006 | cutaneous melanoma | Baylor Health Care System | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | flu matrix peptide p58-66 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003792 ↗ |
| Modality | Peptide | “flu matrix peptide p58-66” NCT00003792 ↗ |